Report #2829784

Received Mar 5, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 41 yrs
State: IL
Recovered: Unknown
Vaccinated: Feb 26, 2025
Onset: Feb 26, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
TDAP	TDAP (BOOSTRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	GH32J	—

Symptoms (1)

Expired product administered

Symptom narrative

received an expired dose of Boostrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 41-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number GH32J, expiry date 29-NOV-2024) for prophylaxis. On 26-FEB-2025, the patient received Boostrix. On 26-FEB-2025, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: received an expired dose of Boostrix). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 26-FEB-2025 The other health professional reported that they administered an expired dose of Boostrix to a female patient on the day of reporting. The other health professional asked does the patient needs to be revaccinated.